no statement of use filed
on 14 Jun 2021
Last Applicant/ Owned by
300 Third Street, 3rd Floor
Cambridge
MA
02142
Serial Number
86776831 filed on 02th Oct 2015
Registration Number
N/A
Correspondent Address
Ann Lamport Hammitte
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
Pharmaceutical preparations, namely, RNA therapeutics for use in the treatment of cancer, HIV, hepatitis A, hepatitis B, influenza, measles, neurodegenerative diseases, transthyretin (TTR)-mediated amyloidosis (ATTR), hemophilia, porphyria, complement-mediated disease, hypercholesterolemia, rare genetic diseases, cardio-metabolic diseases, hepatic infectious diseases, hereditary ATTR amyloidosis, Read More
Pharmaceutical preparations, namely, RNA therapeutics for use in the treatment of cancer, HIV, hepatitis A, hepatitis B, influenza, measles, neurodegenerative diseases, transthyretin (TTR)-mediated amyloidosis (ATTR), hemophilia, porphyria, complement-mediated disease, hypercholesterolemia, rare genetic diseases, cardio-metabolic diseases, hepatic infectious diseases, hereditary ATTR amyloidosis, rare bleeding disorders, hepatic porphyrias, alpha-1 antitrypsin deficiency, primary hyperoxaluria type 1, beta-thalassemia, iron overload disorders, hereditary angiodema, hypertriglyceridemia, mixed hyperlipidemia, hypertriglyceridemia, hypertension, preeclampsia, thromboprophylaxis, hepatitis B virus infection, hepatitis D virus infection, chronic liver infection; Pharmaceuticals, biosimilars and biological preparations for medical and therapeutic purposes for use in the treatment of cancer, HIV, hepatitis A, hepatitis B, influenza, measles, neurodegenerative diseases, transthyretin (TTR)-mediated amyloidosis (ATTR), hemophilia, porphyria, complement-mediated disease, hypercholesterolemia, rare genetic diseases, cardio-metabolic diseases, hepatic infectious diseases, hereditary ATTR amyloidosis, rare bleeding disorders, hepatic porphyrias, alpha-1 antitrypsin deficiency, primary hyperoxaluria type 1, beta-thalassemia, iron overload disorders, hereditary angiodema, hypertriglyceridemia, mixed hyperlipidemia, hypertriglyceridemia, hypertension, preeclampsia, thromboprophylaxis, hepatitis B virus infection, hepatitis D virus infection, chronic liver infection
No 86776831
No Service/Collective Mark
No A2038-2026
No
No
No
No
No
No
No
No
| Status Date | Action Taken |
|---|---|
| 14th Jun 2021 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
| 14th Jun 2021 | ABANDONMENT - NO USE STATEMENT FILED |
| 01st Dec 2020 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 30th Nov 2020 | EXTENSION 5 GRANTED |
| 16th Nov 2020 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| 04th Nov 2020 | TEAS EXTENSION RECEIVED |
| 04th Nov 2020 | EXTENSION 5 FILED |
| 08th May 2020 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 06th May 2020 | EXTENSION 4 GRANTED |
| 06th May 2020 | EXTENSION 4 FILED |
